Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) reported that it has received Institutional Review Board approval to proceed with its clinical trial to treat Type 1 Diabetes with its CELZ-201 cell therapy. The U.S. FDA had previously cleared the Company’s...
Super Micro Soars: Stock Jumps After CFO Appointment and Cleared Investigation
Super Micro Computer Inc. (SMCI), a leading maker of high-performance servers, saw its stock price soar over 20% on Monday morning following a holiday weekend announcement that a recent independent review of the company’s business operations had found no evidence of...
Smucker Braces for RFK Jr.’s Food Reform Policies Under Trump Administration
With Robert F. Kennedy Jr. poised to become the U.S. Secretary of Health under President-elect Donald Trump, food industry giants like The J.M. Smucker Company are carefully watching how his proposed policies on food regulation could impact their business. During his...
Trump’s Bold Tariff Proposal: A Shift in Trade Policy from Day One
On the first day of his presidency, President-elect Donald Trump proposed sweeping tariffs that would drastically change U.S. trade relations with its top partners. In a series of Truth Social posts, Trump outlined plans to impose a 25% tariff on goods from Canada and...